Sims K - Search Results

1

Risk factors for severe clinical events in male and female patients with Fabry disease treated with agalsidase beta enzyme replacement therapy: Data from the Fabry Registry.

Hopkin RJ, Cabrera G, Charrow J, Lemay R, Martins AM, Mauer M, Ortiz A, Patel MR, Sims K, Waldek S, Warnock DG, Wilcox WR. Hopkin RJ, et al. Among authors: sims k. Mol Genet Metab. 2016 Sep;119(1-2):151-9. doi: 10.1016/j.ymgme.2016.06.007. Epub 2016 Jun 13. Mol Genet Metab. 2016. PMID: 27510433 Free article. Clinical Trial.

2

Fabry disease: guidelines for the evaluation and management of multi-organ system involvement.

Eng CM, Germain DP, Banikazemi M, Warnock DG, Wanner C, Hopkin RJ, Bultas J, Lee P, Sims K, Brodie SE, Pastores GM, Strotmann JM, Wilcox WR. Eng CM, et al. Among authors: sims k. Genet Med. 2006 Sep;8(9):539-48. doi: 10.1097/01.gim.0000237866.70357.c6. Genet Med. 2006. PMID: 16980809 Free article. Review.

3

Females with Fabry disease frequently have major organ involvement: lessons from the Fabry Registry.

Wilcox WR, Oliveira JP, Hopkin RJ, Ortiz A, Banikazemi M, Feldt-Rasmussen U, Sims K, Waldek S, Pastores GM, Lee P, Eng CM, Marodi L, Stanford KE, Breunig F, Wanner C, Warnock DG, Lemay RM, Germain DP; Fabry Registry. Wilcox WR, et al. Among authors: sims k. Mol Genet Metab. 2008 Feb;93(2):112-28. doi: 10.1016/j.ymgme.2007.09.013. Epub 2007 Nov 26. Mol Genet Metab. 2008. PMID: 18037317

4

Agalsidase beta treatment is associated with improved quality of life in patients with Fabry disease: findings from the Fabry Registry.

Watt T, Burlina AP, Cazzorla C, Schönfeld D, Banikazemi M, Hopkin RJ, Martins AM, Sims K, Beitner-Johnson D, O'Brien F, Feldt-Rasmussen U. Watt T, et al. Among authors: sims k. Genet Med. 2010 Nov;12(11):703-12. doi: 10.1097/GIM.0b013e3181f13a4a. Genet Med. 2010. PMID: 20885332 Free article.

5

Cardiovascular abnormalities in late-onset Pompe disease and response to enzyme replacement therapy.

Forsha D, Li JS, Smith PB, van der Ploeg AT, Kishnani P, Pasquali SK; Late-Onset Treatment Study Investigators. Forsha D, et al. Genet Med. 2011 Jul;13(7):625-31. doi: 10.1097/GIM.0b013e3182142966. Genet Med. 2011. PMID: 21543987 Free PMC article. Clinical Trial.

6

Analysis of left ventricular mass in untreated men and in men treated with agalsidase-β: data from the Fabry Registry.

Germain DP, Weidemann F, Abiose A, Patel MR, Cizmarik M, Cole JA, Beitner-Johnson D, Benistan K, Cabrera G, Charrow J, Kantola I, Linhart A, Nicholls K, Niemann M, Scott CR, Sims K, Waldek S, Warnock DG, Strotmann J; Fabry Registry. Germain DP, et al. Among authors: sims k. Genet Med. 2013 Dec;15(12):958-65. doi: 10.1038/gim.2013.53. Epub 2013 May 23. Genet Med. 2013. PMID: 23703683 Free article.

7

Open-label extension study following the Late-Onset Treatment Study (LOTS) of alglucosidase alfa.

van der Ploeg AT, Barohn R, Carlson L, Charrow J, Clemens PR, Hopkin RJ, Kishnani PS, Laforêt P, Morgan C, Nations S, Pestronk A, Plotkin H, Rosenbloom BE, Sims KB, Tsao E. van der Ploeg AT, et al. Mol Genet Metab. 2012 Nov;107(3):456-61. doi: 10.1016/j.ymgme.2012.09.015. Epub 2012 Sep 17. Mol Genet Metab. 2012. PMID: 23031366 Clinical Trial.

8

Cardiovascular manifestations of Fabry disease: relationships between left ventricular hypertrophy, disease severity, and alpha-galactosidase A activity.

Wu JC, Ho CY, Skali H, Abichandani R, Wilcox WR, Banikazemi M, Packman S, Sims K, Solomon SD. Wu JC, et al. Among authors: sims k. Eur Heart J. 2010 May;31(9):1088-97. doi: 10.1093/eurheartj/ehp588. Epub 2010 Jan 7. Eur Heart J. 2010. PMID: 20061327 Free PMC article. Clinical Trial.

9

Fabry disease practice guidelines: recommendations of the National Society of Genetic Counselors.

Laney DA, Bennett RL, Clarke V, Fox A, Hopkin RJ, Johnson J, O'Rourke E, Sims K, Walter G. Laney DA, et al. Among authors: sims k. J Genet Couns. 2013 Oct;22(5):555-64. doi: 10.1007/s10897-013-9613-3. Epub 2013 Jul 17. J Genet Couns. 2013. PMID: 23860966

10

Cognitive function in adults aging with fabry disease: a case-control feasibility study using telephone-based assessments.

Wadley VG, McClure LA, Warnock DG, Lassen-Greene CL, Hopkin RJ, Laney DA, Clarke VM, Kurella Tamura M, Howard G, Sims K. Wadley VG, et al. Among authors: sims k. JIMD Rep. 2015;18:41-50. doi: 10.1007/8904_2014_346. Epub 2015 Jan 8. JIMD Rep. 2015. PMID: 25567791 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

388 results

Search Page